Recent Advances in Liver Tissue Engineering as an Alternative and Complementary Approach for Liver Transplantation

Area of Science:

• Regenerative Medicine
• Hepatology
• Biomedical Engineering

Background:

• Acute and chronic liver diseases represent a major global health burden, leading to significant morbidity and mortality.
• Liver transplantation is the current gold standard for end-stage liver disease but faces limitations including donor scarcity and post-operative challenges.
• Existing therapeutic options are insufficient, necessitating the exploration of novel treatment strategies.

Purpose of the Study:

• To review the potential of liver tissue engineering as a complementary or alternative therapy to liver transplantation.
• To highlight the benefits of tissue-engineered liver constructs for patients with severe liver dysfunction.
• To discuss the current state and future prospects of liver tissue engineering in clinical practice.

Main Methods:

• Literature review of current research in liver tissue engineering and regenerative medicine.
• Analysis of studies focusing on scaffold development, cell sourcing, and bioreactor technologies for liver tissue fabrication.
• Evaluation of preclinical and clinical data on the efficacy and safety of engineered liver tissues.

Main Results:

• Liver tissue engineering demonstrates potential in creating functional liver grafts.
• Advances in biomaterials, stem cell biology, and biomanufacturing are enabling the development of more sophisticated liver constructs.
• Engineered tissues show promise in preclinical models for detoxification, metabolic functions, and bile production.

Conclusions:

• Liver tissue engineering presents a viable strategy to overcome the limitations of liver transplantation.
• Further research and clinical translation are crucial to realize the full therapeutic potential of engineered livers.
• This innovative field offers hope for improved patient outcomes in liver disease management.